230 related articles for article (PubMed ID: 12553324)
1. Bladder-sparing procedure as good as cystectomy for treating invasive bladder cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):7-9. PubMed ID: 12553324
[No Abstract] [Full Text] [Related]
2. Current status of radiation therapy and combined-modality treatment for bladder cancer.
Rödel C
Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
Choueiri TK; Raghavan D
Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
[TBL] [Abstract][Full Text] [Related]
4. [Combined therapy for patients with invasive bladder cancer].
Startsev VIu; Karelin MI
Vopr Onkol; 2003; 49(2):235-8. PubMed ID: 12785212
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options and treatment of muscle invasive bladder cancer.
O'Connor RC; Alsikafi NF; Steinberg GD
Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
[TBL] [Abstract][Full Text] [Related]
6. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
8. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
Merseburger AS; Kuczyk MA
Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
[TBL] [Abstract][Full Text] [Related]
9. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
[TBL] [Abstract][Full Text] [Related]
10. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
[TBL] [Abstract][Full Text] [Related]
11. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
12. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.
Weiss C; Wittlinger M; Engehausen DG; Krause FS; Ott OJ; Dunst J; Sauer R; Rödel C
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1502-6. PubMed ID: 17935905
[TBL] [Abstract][Full Text] [Related]
13. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
Pansadoro V; Emiliozzi P
Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
[TBL] [Abstract][Full Text] [Related]
14. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
15. Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?
Madersbacher S; Thalmann GN; Fritsch JC; Studer UE
J Clin Oncol; 2004 Oct; 22(20):4103-8. PubMed ID: 15483019
[TBL] [Abstract][Full Text] [Related]
16. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors.
Zietman AL; Sacco D; Skowronski U; Gomery P; Kaufman DS; Clark JA; Talcott JA; Shipley WU
J Urol; 2003 Nov; 170(5):1772-6. PubMed ID: 14532773
[TBL] [Abstract][Full Text] [Related]
17. Alternatives to cystectomy in muscle-invasive bladder cancer.
Goel S
J Clin Oncol; 2003 Aug; 21(15):3003; author reply 3003-4. PubMed ID: 12885826
[No Abstract] [Full Text] [Related]
18. [The role of preserving therapy of invasive cancer of the urinary bladder].
Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
Urologiia; 2005; (6):3-6. PubMed ID: 16419470
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]